Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage viaangiotensin II

Journal of Physiology and Pharmacology

Volumn 61, Issue 2, 2010, Pages 171-179

  Nakagiri, A ^a,b   Sunamoto, M ^a   Takeuchi, K ^b   Murakami, M ^a  

^a DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

AT1 receptor; Gastric damage; Ischemia reperfusion; NADPH oxidase; Reactive oxygen species

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CANDESARTAN; DIPHENYLIODONIUM SALT; ENALAPRIL; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; LOSARTAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; URETHAN; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CATION; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBUNIT; EX VIVO STUDY; FEMORAL VEIN; INTRAVENOUS CATHETER; ISCHEMIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; STOMACH INJURY; STOMACH MUCOSA; ANIMAL; DISEASE MODEL; ENZYMOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; ENALAPRIL; ENZYME INHIBITORS; GASTRIC MUCOSA; HYDROGEN PEROXIDE; MALE; NADPH OXIDASE; ONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 77955899211     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of nonsteroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336: 480-843.
2. Ishii M, Shimizu S, Nawata S, Kiuchi Y, Yamamoto T. Involvement of reactive oxygen species and nitric oxide in gastric ischemia-reperfusion injury in rats: protective effect of tetrahydrobiopterin. Dig Dis Sci 2000; 45: 93-98.
3. Obst B, Wagner S, Sewing KF, Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 2000; 21: 1111-1115.
4. Kwiecien S, Brzozowski T, Konturek SJ. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol 2002; 53: 39-50.
5. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994; 266: H2568-H2572.
6. Mohazzab KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol 1994; 267: L815-L822.
7. Li AE, Ito H, Rovira II, et al. A role for reactive oxygen species in endothelial cell anoikis. Circ Res 1999; 85: 304-310.
8. Rey FE, Pagano PJ. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 2002; 22: 1962-1971.
9. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
10. El Benna J, Ruedi JM, Babior BM. Cytosolic guanine nucleotide-binding protein Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase. Transfer of Rac2 and the cytosolic oxidase components p47phox and p67phox to the submembranous actin cytoskeleton during oxidase activation. J Biol Chem 1994; 269: 6729-6734.
11. Johansson A, Jesaitis AJ, Lundqvist H, et al. Different subcellular localization of cytochrome b and the dormant NADPH-oxidase in neutrophils and macrophages: effect on the production of reactive oxygen species during phagocytosis. Cell Immunol 1995; 161: 61-71.
12. DeLeo FR, Allen LA, Apicella M, Nauseef WM. NADPH oxidase activation and assembly during phagocytosis. J Immunol 1999; 163: 6732-6740.
13. Grafe M, Auch-Schwelk W, Zakrzewicz A, et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 1997; 81: 804-811.
14. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascularsmooth muscle cells. Hypertension 1999; 34: 976-982.
15. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin IImediated hypertension in the rat increases vascular superoxide to production via membrane NADH/NADPH oxidase activation. J Clin Invest 1996; 97: 1916-1923.
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148.
17. Heinemann A, Sattler V, Jocic M, Wienen W, Holzer P. Effect of angiotensin II and telmisartan, an angiotensin 1 receptor antagonist, on gastric mucosal blood flow. Aliment Pharmacol Ther 1999; 13: 347-355.
18. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 2003; 285: G414-G423.
19. Murakami M, Saita H, Teramura S, et al. Gastric ammonia has a potent uclerogenic action on the rat stomach. Gastroenterology 1993; 105: 1710-1715.
20. Komoike Y, Nakashima M, Nakagiri A, Takeuchi K. Prostaglandin E receptor EP1 subtype but not prostacyclin IP receptor involved in mucosal blood flow response of mouse stomachs following barrier disruption. Digestion 2003; 67: 186-194.
21. Takeuchi K, Furukawa O, Nishiwaki H, Okabe S. 16,16-Dimethyl prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats: possible role of the increased mucosal vascular permeability. Gastroenterology 1987; 93: 1276-1286.
22. Katayama S, Shionoya H, Ohtake S. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol 1978; 22: 89-101.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-159.
24. Pawlik MW, Sendur R, Biernat J, Brzozowski T, Konturek SJ, Pawlik WW. Inhibition of the rennin-angiotensin system protects gastric mucosa against ischemia/reperfusion injury. Gastroenterology 2001; 120(Supl 1): A196, 1031.
25. Petnehazy T, Cooper D, Stokes D, et al. Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1203-G1210.
26. Riaz AA, Wang Y, Schramm R, et al. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 2004; 18: 881-883.
27. Anthuber M, Farkas S, Rihl M, et al. Angiotensin-converting enzyme inhibition by enalapril: a novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. Hepatology 1997; 25: 648-651.
28. Olszanecki R, Madej J, Suski M, Gebska A, Bujak-Gizycka B, Korbut R. Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-(1-7) formation. J Physiol Pharmacol 2009; 60: 191-196.
29. Li JM, Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002; 277: 19952-19960.
30. Allen LA, Beecher BR, Lynch JT, Rohner OV, Wittine LM. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J Immunol 2005; 174: 3658-3667.
31. Suh YA, Arnold RS, Lassegue B, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
32. El Hssani RA, Benfares N, Cailou B, et al. Dual oxidase 2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 2005; 288: G933-G942.
33. Teshima S, Rokutan K, Nikawa T, Kishi K. Guinea pig gastric mucosal cells produce abundant superoxide anion through an NADPH oxidasee-like system. Gastroenterology 1998; 115: 1186-1196.
34. Nakagiri A, Sunamoto M, Murakami M. NADPH oxidase is involved in ischemia/reperfusion-induced damage in rat gastric mucosa via ROS production - role of NADPH oxidase in rat stomachs. Inflammopharmacology 2007; 15: 278-281.
35. Ago T, Kitazono T, Kuroda J, et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 2005; 36: 1040-1046.
36. Dai X, Cao X, Kreulen DL. Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase. Am J Physiol Heart Circ Physiol 2006; 290: H1019-H1026.
37. Sadowski J, Badzynska B. Intrarenal vasodilator systems: NO, prostaglandins and bradykinin. An integrative approach. J Physiol Pharmacol 2008; 59: 105-119.
38. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethyleneglycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterolfed rabbits. Circ Res 1991; 69(5): 1293-1300.
39. Okajima K, Harada N, Uchiba M. Ranitidine reduces ischemia/reperfusion-induced liver injury in rats by inhibiting neutrophil activation. J Pharmacol Exp Ther 2002; 301: 1157-1165.
40. Kimura S, Zhang GX, Nishiyama A, et al. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 2005; 45: 860-866.
41. Oldenburg O, Qin Q, Krieg T, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 2004; 286: H486-H476.
42. Pain T, Yang XM, Liu GS, et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 2001; 87: 460-466.
43. Czesnikiewicz-Guzik M, Lorkowska B, Zapala J, et al. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. J Physiol Pharmacol 2008; 59: 139-152.